|Number of pages||1|
|Journal||Annals of Oncology|
|Publication status||Published - Sep 2017|
|Event||42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain|
Duration: 8 Sep 2017 → 12 Sep 2017
Lickliter, J., Gan, H. K., Gao, B., Grimison, P., Zou, J., Kallender, H., Sun, K., Chen, X., Behren, A., Fernandez-Penas, P., Nagrial, A., Voskoboynik, M., Woods, K., Millward, M., & Meniawy, T. (2017). A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer. Annals of Oncology, 28.